title: Relapse of primary CNS lymphoma after more than 10 years in complete remission.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Herrlinger
authors.forename: Holger
authors.initials: H
authors.lastname: Hebart
authors.forename: Lothar
authors.initials: L
authors.lastname: Kanz
authors.forename: Johannes
authors.initials: J
authors.lastname: Dichgans
authors.forename: Michael
authors.initials: M
authors.lastname: Weller
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology* / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology* / Q000628:therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011344:Procarbazine / Q000627:therapeutic use; D000077204:Temozolomide; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D011344:Procarbazine; D014750:Vincristine; D003606:Dacarbazine; D000077204:Temozolomide; D008727:Methotrexate